Title : Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents.

Pub. Date : 2010 Feb 4

PMID : 20132536






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 One of the HDAC inhibitors, vorinostat, has been approved by FDA for treating cutaneous T-cell lymphoma (CTCL) for patients with progressive, persistent, or recurrent disease on or following two systemic therapies. Vorinostat TSPY like 2 Homo sapiens